Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults

Journal of Alzheimer's Disease

Volumn 35, Issue 2, 2013, Pages 253-265

  Watts, Amber S ^a   Loskutova, Natalia ^b   Burns, Jeffrey M ^a,b   Johnson, David K ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; cognitive decline; factor analysis; metabolic syndrome

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METABOLIC SYNDROME X; PRIORITY JOURNAL; RISK FACTOR; VERBAL MEMORY;

EID: 84877157543     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121168     Document Type: Article

References (61)

1. Craft S (2005) Insulin resistance syndrome and Alzheimer's disease: Age-And obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26(Suppl 1), 65-69
2. Handschin C, Spiegelman BM (2008) The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454, 463-469
3. Greenwood CE, Winocur G (2005) High-fat diets, insulin resistance and declining cognitive function. Neurobiol Aging 26(Suppl 1), 42-45
4. Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, MartinsRN(2006) Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 11, 721-736
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-Aged men. JAMA 288, 2709-2716
6. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA (2002) Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156, 1070-1077
7. Onat A, Ceyhan K, Basar O, Erer B, Toprak S, Sansoy V (2002) Metabolic syndrome: Major impact on coronary risk in a population with low cholesterol levels-A prospective and cross-sectional evaluation. Atherosclerosis 165, 285-292
8. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: The Three-City Study. Diabetes Care 32, 169-174
9. Razay G, Vreugdenhil A, Wilcock G (2007) The metabolic syndrome and Alzheimer disease. Arch Neurol 64, 93-96
10. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J (2006) Association of metabolic syndrome with Alzheimer disease: A population-based study. Neurology 67, 843-847
11. Segura B, Jurado MA, Freixenet N, Albuin C, Muniesa J, Junque C (2009) Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 462, 49-53
12. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J,Westendorp RG (2007) The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69, 979-985
13. Cavalieri M, Ropele S, Petrovic K, Pluta-Fuerst A, Homayoon N, Enzinger C, Grazer A, Katschnig P, Schwingenschuh P, Berghold A, Schmidt R (2010) Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care 33, 2489-2495
14. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW (2007) Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30, 2655-2660
15. Gatto NM, Henderson VW, St John JA, McCleary C, Hodis HN, Mack WJ (2008) Metabolic syndrome and cognitive function in healthy middle-Aged and older adults without diabetes. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 15, 627-641
16. Isik AT, Cankurtaran M, Bozoglu E, Comert B, Doruk H, Mas MR (2007) Is there any relation between insulin resistance and cognitive function in the elderly? Int Psychogeriatr 19, 745-756
17. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192
18. Choi SJ, Jung SS, You YS, Shin BS, Kim JE, Yoon SW, Jeon DW, Baek JH, Park SW, Lee JG, Kim YH (2008) Prevalence of Alzheimer's dementia and its risk factors in communitydwelling elderly koreans. Psychiatry Investig 5, 78-85
19. Forti P, Pisacane N, Rietti E, Lucicesare A, OlivelliV, Mariani E, Mecocci P, RavagliaG(2010) Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 58, 487-492
20. Crichton GE, Elias MF, Buckley J,Murphy KJ, Bryan J, Frisardi V (2012) Metabolic syndrome, cognitive performance, and dementia. J Alzheimers Dis 30(Suppl 2), S77-S87
21. BollenKA(1989) Structural Equations with LatentVariables, Wiley, New York
22. Burns JM, Honea RA, Vidoni ED, Hutfles LJ, Brooks WM, Swerdlow RH (2012) Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging. Biochim Biophys Acta 1822, 333-339
23. Murray IV, Proza JF, Sohrabji F, Lawler JM (2011) Vascular and metabolic dysfunction in Alzheimer's disease: A review. Exp Biol Med (Maywood) 236, 772-782
24. Burns JM, Johnson DK,Watts A, Swerdlow RH, BrooksWM (2010) Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 67, 428-433
25. Johnson DK, Wilkins CH, Morris JC (2006) Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol 63, 1312-1317
26. Mielke MM, Zandi PP, Sjogren M, Gustafson D, Ostling S, Steen B, Skoog I (2005) High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64, 1689-1695
27. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N (2007) Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55, 758-762
28. Knopman DS, Mosley TH, Catellier DJ, Coker LH, Atherosclerosis Risk in Communities Study Brain MRIS (2009) Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: The ARIC MRI Study. Alzheimers Dement 5, 207-214
29. Burns JM, Donnelly JE, Anderson HS, Mayo MS, Spencer-Gardner L, Thomas G, Cronk BB, Haddad Z, Klima D, Hansen D, Brooks WM (2007) Peripheral insulin and brain structure in early Alzheimer disease. Neurology 69, 1094-1104
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944
31. Morris JC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43, 2412-2414
32. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L (2001) Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 58, 397-405
33. Storandt M, Grant EA, Miller JP, Morris JC (2006) Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology 67, 467-473
34. Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM (1998) Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55, 326-335
35. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, ReavenG, Hama Sambo B, Mendis S, Roglic G (2010) The metabolic syndrome: Useful concept or clinical tool? Report of aWHOExpert Consultation. Diabetologia 53, 600-605
36. Whittaker ET, Robinson G (1967) The trapezoidal and parabolic rules. In The Calculus of Observations: A Treatise on Numerical Mathematics, 4th Edition. Dover, New York, pp. 156-158
37. Johnson DK, Storandt M, Morris JC, Langford ZD, Galvin JE (2008) Cognitive profiles in dementia: Alzheimer disease vs healthy brain aging. Neurology 71, 1783-1789
38. Fedder DO, Koro CE, L'Italien GJ (2002) New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: Projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation 105, 152-156
39. Muthen LK, Muthen BO (2007) Mplus User's Guide. Fifth Edition. Muthen & Muthen, Los Angeles, C.A.
40. Preacher KJ, MacCallum RC (2003) Repairing Tom Swift's electric factor analysis machine. Understanding Statistics 2, 13-43
41. Horn JL, McArdle JJ (1992) A practical and theoretical guide to measurement invariance in aging research. Exp Aging Res 18, 117-144
42. Cheung G, Rensvold R (2002) Evaluating goodness-of-fit indexes for testing measurement invariance. Struct Equ Modeling 9, 233-255
43. Johnson DK, Storandt M, Morris JC, Galvin JE (2009) Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol 66, 1254-1259
44. Kumari M, Brunner E, Fuhrer R (2000) Minireview: Mechanisms by which the metabolic syndrome and diabetes impair memory. J Gerontol A Biol Sci Med Sci 55, B228-B232
45. Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes 56, 211-216
46. Peila R, Rodriguez BL, White LR, Launer LJ (2004) Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 63, 228-233
47. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63, 1187-1192
48. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63, 658-663
49. Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B (2009) Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology 73, 1359-1366
50. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch Neurol 69, 29-38
51. Reger MA,Watson GS, Green PS,Wilkinson CW, Baker LD, Cholerton B, Fishel MA, Plymate SR, Breitner JC, DeGroodt W, Mehta P, Craft S (2008) Intranasal insulin improves cognition and modulates beta-Amyloid in early AD. Neurology 70, 440-448
52. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laakso M (1997) Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross sectional population based study. BMJ 315, 1045-1049
53. Craft S, Peskind E, SchwartzMW, Schellenberg GD, Raskind M, Porte D Jr (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype. Neurology 50, 164-168
54. Watson GS, Craft S (2003) The role of insulin resistance in the pathogenesis of Alzheimer's disease: Implications for treatment. CNS Drugs 17, 27-45
55. Perry RJ, Hodges JR (1999) Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122(Pt 3), 383-404
56. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR Jr, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ, Alzheimer's Disease Cooperative S (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61, 59-66
57. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R (2007) Metabolic syndrome and cognitive function:Apopulation-based followup study in elderly women. Dement Geriatr Cogn Disord 23, 29-34
58. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM (1996) Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 39, 1392-1397
59. Elias PK, EliasMF, D'Agostino RB, Cupples LA,WilsonPW, Silbershatz H,Wolf PA (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 20, 1388-1395
60. Vanhanen M, Koivisto K, Karjalainen L, Helkala EL, Laakso M, Soininen H, Riekkinen P Sr (1997) Risk for noninsulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function. Neuroreport 8, 1527-1530
61. van den Berg E, Dekker JM, Nijpels G, Kessels RP, Kappelle LJ, de Haan EH, Heine RJ, Stehouwer CD, Biessels GJ (2008) Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn study. Dement Geriatr Cogn Disord 26, 261-269